PATENT CLAIM ANALYSIS

Application Number: 15554354
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-06
Patent Classification: ["514", "211060"]

Abstract:
The present invention relates to bicyclic tetrahydrothiazepine of formula (I), wherein R 1  to R 3 , X 1 , X 2  and R 18  have the meaning as indicated in the description and claims. The invention further relates to pharmaceutical compositions comprising such compounds as well as their use as medicaments, especially in methods for the treatment or prevention of a neoplastic and/or infectious disease and in vitro methods.

Claim (Index 45):
A method of treating or preventing a neoplastic and/or infectious disease in a patient, comprising administering to said patient an amount of a compound or pharmaceutically acceptable salt thereof as defined in  claim 28  sufficient for treating or preventing said neoplastic and/or infectious disease in said patient.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.46154
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12295545', '12096393', '13128726', '12096432', '12096439']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.763172484835336
- 35 USC 102 Novelty (BERT): 0.5397758339513354
- Combined Prediction Score: 0.7408328197469359
- Mean Citation Score: 343.96614400000016
- Max Citation Score: 368.7808
- Similarity Product: 226.25020770034791

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test